Gynecological diseases as predictors of female sexual dysfunction

GYNECOLOGY ◽  
2021 ◽  
Vol 23 (2) ◽  
pp. 149-154
Author(s):  
Natalia N. Stenyaeva ◽  
Dmitrii F. Chritinin ◽  
Andrei A. Chausov
Keyword(s):  
Sexual Dysfunction ◽  
Sexual Health ◽  
Sexual Function ◽  
Sexual Functioning ◽  
Female Sexual Dysfunction ◽  
Sexual Dysfunctions ◽  
Female Sexual Function ◽  
Gynecological Diseases ◽  
Screening Assessment ◽  
Outpatient Appointments

Background. Female sexual dysfunction is extremely common and affects about half of the worlds women. Currently, the question of the relationship between gynecological morbidity in women and the characteristics of sexual activity and sexual functioning in a couple remains poorly understood. Aim. To establish gynecological diseases associated with decreased sexual functioning, sexual health disorders in women on the basis of a screening assessment when visiting the clinic. Materials and methods. We conducted a cross-sectional descriptive study of the sexual functioning of 1256 women who presented to outpatient appointments. Anamnestic and clinical methods were used, sexological testing using the Female Sexual Function Index questionnaire. Results. Based on anamnestic data, screening assessment of sexual health and sexual functioning of 1235 women who applied for outpatient appointments to a gynecological clinic, a high gynecological and extragenital morbidity was established in patients (100%). The structure of gynecological diseases is represented by female infertility (48.3%), inflammatory diseases of the genital organs (38.5%; of which salpingo-oophoritis 16.6% and vulvovaginitis 15.9%), endometriosis (13.9%) , menstrual irregularities (8.3%), as well as pain disorders (8.1%). The incidence of infections, predominantly sexually transmitted, was revealed, among them papillomatous viral infection (8.3%), genital herpes (5.3%) and chlamydia (3.7%). It was found that in gynecological patients with diseases characterized by a chronic course, inflammation, pelvic pain, menstrual and reproductive disorders, sexual functioning significantly decreases (p=0.00) and sexual health is impaired. Sexual dysfunctions were detected in 21.6% of patients, their structure is represented by isolated (39.3%) and combined (60.7%) disorders of libido, orgasm, sexual anhedonia, failure of genital response, as well as dyspareunia, vaginismus. In 33.7% of patients, preclinical forms of sexual dysfunction were identified that did not meet the criteria for sexual dysfunction (did not cause distress, were short-lived), but confirmed by the analysis of patient complaints, as well as by the results of the Female Sexual Function Index questionnaire. Conclusion. Thus, chronic gynecological diseases with inflammatory manifestations, pelvic pain, menstrual and reproductive dysfunctions are associated with decreased sexual functioning, sexual dysfunctions, and preclinical forms of sexual dysfunctions.

scholarly journals Assessing Sexual Function of Women after 12 Months of IUD Usage

2020 ◽  
Vol 1 (1) ◽  
pp. 12-18
Author(s):  
Emmanuel Lamptey ◽  
Adesina oladokun ◽  
Michael A. Okunlola
Keyword(s):  
Sexual Dysfunction ◽  
Sexual Health ◽  
Sexual Function ◽  
Sexual Satisfaction ◽  
Female Sexual Dysfunction ◽  
Intrauterine Device ◽  
Female Sexual Function Index ◽  
Female Sexual Function ◽  
Underlying Condition ◽  
Longitudinal Approach

The Intrauterine Device (IUD) is a well-accepted method of contraception. Most women are currently using it because of its effectiveness, longevity, and affordability. Moreover, users need no strict routine instructions for IUD. However, many women in the absence of any pre-existing conditions that may impair sexual functions discontinue the method due to poor sexual satisfaction. This paper aims to assess and measure the effects of IUDs on sexual function in women with no underlying condition over a period of 12 months. This study employed a longitudinal approach. To be eligible to participate, the study enrolled 260 women who have chosen to use IUDs willingly on their own at these selected centers during this period and are aged 20 years and above. It collected data at baseline and at 12 months of use. Measurements at these two timelines were done using the Female Sexual Function Index (FSFI). The prevalence of female sexual dysfunction among participants after 12 months was 47.7% (124). In the analysis of Mean scores, FSFI at baseline and at 12 months was 31.31 and 24.76 respectively (p<0.05). Significantly reduced scores (p=0.001), for all the six domains (desire, arousal, lubrication, orgasm, satisfaction, and pain) of sexual function were noted. Desire and pain were the most affected areas of sexual function with very low scores. Without any underlying and related triggers of sexual health, the study discovered that IUDs have the potentials to cause female sexual dysfunction in almost half of its users.

Impact of Infertility Duration on Female Sexual Health

2021 ◽  
Author(s):  
Meng Dong ◽  
Xiaoyan Xu ◽  
Yining Li ◽  
Yixian Wang ◽  
Zhuo Jin ◽  
...  
Keyword(s):  
Risk Factor ◽  
Sexual Dysfunction ◽  
Sexual Health ◽  
Sexual Function ◽  
Equation Model ◽  
Sexual Life ◽  
Female Sexual Function ◽  
Psychological Pain ◽  
Multivariable Logistic Regression Model ◽  
Group I

Abstract BackgroundAs an important source of stress, infertility may affect the quality of sexual life, with extensive studies believing that the incidence of sexual dysfunction in infertile women is highly prevalent. As the years of infertility increase, the greater this stress is likely to increase, which may aggravate psychological pain and cause sexual dysfunction. However, the effect of infertility duration on sexual health is unclear.Methods We performed a case-control study, and a total of 715 patients participated in this research between September 1, 2020, and December 25, 2020. Patients diagnosed with infertility (aged between 20 to 45 years) were included. Patients with infertility were divided into four groups according to infertility duration: ≤ 2 years (Group I, n=262), 2< infertility duration ≤5 years (Group II, n=282), 5 < infertility duration ≤8 years (Group III, n=97), and infertility duration > 8 years (Group IV, n=74). A questionnaire survey of female sexual function and psychological depression of patients with infertility was performed. The female sexual function was measured by the Female Sexual Function Index (FSFI), depression status was measured by the Patient Health Questionnaire (PHQ-9).ResultsAnalysis of the relevant factors that affect sexual function using a multivariable logistic regression model revealed that infertility duration of less than 8 years was not a risk factor for sexual dysfunction. However, when infertility duration was greater than 8 years, the incidence of sexual dysfunction (AOR=5.158,95%CI: 1.935-13.746, P=0.001) and 3 domains [arousal disorder (AOR=2.955 ,95%CI: 1.194-7.314, P=0.019, coital pain (AOR=3.811 ,95%CI: 1.045-13.897, P=0.043), and lubrication disorder (AOR=5.077 ,95%CI: 1.340-19.244, P=0.017)] increases. ConclusionsThe multivariate regression equation model reveals that the infertility duration is more than 8 years, which is a risk factor for the occurrence of sexual dysfunction. As the infertility duration increases, the incidence of female sexual dysfunction and psychological distress may increase.

scholarly journals The Effectiveness of Psycho-Educational and Cognitive-Behavioral Counseling on Female Sexual Dysfunction

2020 ◽  
Vol 42 (06) ◽  
pp. 333-339
Author(s):  
Firoozeh Mirzaee ◽  
Atefeh Ahmadi ◽  
Zahra Zangiabadi ◽  
Moghaddameh Mirzaee
Keyword(s):  
Sexual Dysfunction ◽  
Sexual Function ◽  
Female Sexual Dysfunction ◽  
Intervention Group ◽  
Cognitive Behavioral ◽  
Future Research ◽  
Control Group ◽  
Cutoff Score ◽  
Female Sexual Function ◽  
Behavioral Counseling

Abstract Introduction Sexual function is a multidimensional phenomenon that is affected by many biological and psychological factors. Cognitive-behavioral sex therapies are among the most common nonpharmacological approaches to psychosexual problems. The purpose of the present study was to investigate the effectiveness of psychoeducational and cognitive-behavioral counseling on female sexual dysfunction. Methods The present study was a clinical trial with intervention and control groups. The study population consisted of women referring to the general clinic of a governmental hospital in Iran. After completing the demographic questionnaire and Female Sexual Function Index (FSFI), those who obtained the cutoff score ≤ 28 were contacted and invited to participate in the study. Convenience sampling method was used and 35 subjects were randomly allocated for each group. Eight counseling sessions were held for the intervention group (two/week/1.5 hour). Post-test was taken from both groups after 1 month, and the results were statistically analyzed by PASW Statistics for Windows, Version 18 (SPSS Inc., Chicago, IL, USA). Results The total mean scores of FSFI and the subscales of sexual desire, arousal, orgasm, and satisfaction were significantly higher in the intervention group than in the control group after the intervention. In addition, postintervention pain mean scores in the intervention group were significantly lower than in the control group (p < 0.05). Conclusion The results of the present study indicate that psychoeducational cognitive-behavioral counseling is effective in improving female sexual function. It is recommended to compare the effects of psychoeducational cognitive-behavioral counseling on sexual dysfunctions of couples and with a larger sample size in future research.

scholarly journals Depression, Anxiety and Sexual Dysfunction Among Jordanian Women With Type 2 Diabetes Mellitus

2020 ◽  
Author(s):  
Zaina Alazawi ◽  
Ola Alqudah ◽  
Ahmad Al-Bashaireh
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Sexual Dysfunction ◽  
Sexual Function ◽  
Female Sexual Dysfunction ◽  
Female Sexual Function Index ◽  
Female Sexual Function ◽  
Arabic Version

The aims of this study are to determine the prevalence of sexual dysfunction and to examine the relationships of sexual function and psychological factors of depression and anxiety and diabetes-related factors in Jordanian women with type 2 diabetes mellitus. This study employed a cross-sectional, descriptive, correlational design. All eligible participants with type 2 diabetes mellitus were consequently recruited from primary care centers. All enrolled participants were asked to complete questionnaires: Arabic version of the Female Sexual Function Index, Beck Depression Inventory-II, Beck Anxiety Inventory, and demographic questionnaires. Physical and biological measures were collected from the patient's medical records. 107 women with type 2 diabetes mellitus were recruited with a mean of age of 52.46±8.38 years. The prevalence of female sexual dysfunction was 94.4%. Regarding the mean scores of the Arabic version of the Female Sexual Function Index domains, the highest mean score was for pain (5.09±1.51), and the lowest mean score was for sexual arousal (2.44±1.28). This study found significant inverse relationships between female sexual function and age (r= -0.340, P<0.01), duration of diabetes (r= -0.211, P=0.029), fasting blood sugar (r= -0.234, P=0.015), anxiety (r= -0.375, P<0.01), and depression (r= -0.480, P<0.01). Our study found female sexual dysfunction is widely prevalent in Jordanian women with type 2 diabetes mellitus (94.4%). There were significant correlations between anxiety, depression, and female sexual function among women with type 2 diabetes mellitus.

scholarly journals Female sexual dysfunction in multiple system atrophy: a prospective cohort study

2021 ◽  
Author(s):  
Cecilia Raccagni ◽  
Elisabetta Indelicato ◽  
Victoria Sidoroff ◽  
Martin Daniaux ◽  
Angelika Bader ◽  
...  
Keyword(s):  
Sexual Dysfunction ◽  
Multiple System Atrophy ◽  
Sexual Function ◽  
Female Sexual Dysfunction ◽  
Autonomic Failure ◽  
Female Sexual Function Index ◽  
Motor Symptoms ◽  
Female Sexual Function ◽  
Sexually Active ◽  
Function Index

Abstract Purpose The diagnosis of probable multiple system atrophy relies on the presence of severe cardiovascular or urogenital autonomic failure. Erectile dysfunction is required to fulfil the latter criterion in men, whereas no corresponding item is established for women. In this study, we aimed to investigate sexual dysfunction in women with multiple system atrophy. Methods We administered the Female Sexual Function Index questionnaire and interviewed women with multiple system atrophy and age-matched controls regarding the presence of “genital hyposensitivity.” Results We recruited 25 women with multiple system atrophy and 42 controls. Female Sexual Function Index scores in sexually active women with multiple system atrophy were significantly lower (multiple system atrophy = 10; 15.4, 95% CI [10.1, 22.1], controls = 37; 26.1 [24.1, 28.1], p = 0.0004). The lowest scores concerned the domains of desire, arousal and lubrication. Genital hyposensitivity was reported by 56% of the patients with multiple system atrophy and 9% controls (p < 0.0001). Conclusions Sexual dysfunction is highly prevalent in women with multiple system atrophy. Screening for disturbances in specific sexual domains should be implemented in the clinical evaluation of women with suggestive motor symptoms.

The New Avatar of Female Sexual Dysfunction in ICD-11—Will It Herald a Better Future?

2019 ◽  
Vol 1 (2) ◽  
pp. 111-113
Author(s):  
Soumya Parameshwaran ◽  
Prabha S. Chandra
Keyword(s):  
Clinical Practice ◽  
Sexual Dysfunction ◽  
Sexual Health ◽  
Female Sexual Dysfunction ◽  
Sexual Problems ◽  
Sexual Dysfunctions ◽  
Diagnosis And Management

Female sexual dysfunction has always had challenges related to nosological issues due to inadequate research and understanding in this area. The ICD-11 has proposed substantial changes to the classification of conditions related to sexual health. In this review, we have discussed the proposed changes, compared with other classificatory systems and discussed its implications on clinical practice and research in this field. While there have been several progressive moves in the taxonomy of sexual dysfunctions, we have expressed our views on possible changes which can help with better diagnosis and management of sexual problems in women.

Female sexual dysfunction and associated co-morbidities: a cross sectional study with Female Sexual Function Index (FSFI) in a tertiary care hospital of Bangladesh

2020 ◽  
Vol 30 (2) ◽  
pp. 27-31 ◽  
Author(s):  
Mohammad Shamsul Ahsan ◽  
Shahjada Selim ◽  
Srijony Ahmed ◽  
Rubaiya Ali ◽  
Hosnea Ara ◽  
...  
Keyword(s):  
Sexual Health ◽  
Sexual Function ◽  
Cross Sectional Study ◽  
Female Sexual Function Index ◽  
Sexual Dysfunctions ◽  
Female Sexual Function ◽  
Age Group ◽  
Sectional Study ◽  
Cross Sectional ◽  
Function Index

Talks regarding sexual problems are not encouraging in Bangladesh and sufferers are in grave situation as they are not sure regarding whom to approach and how to start. It was aimed to see the presenting patterns of female sexual dysfunctions (FSD) and co-morbidities among the patients attending at different outpatient departments (OPD) at Bangabandhu Sheikh Mujib Medical University (BSMMU). This descriptive cross sectional study was conducted among 173 female patients attending at gynecology, endocrinology and psychiatry OPD, BSMMU. Sample was taken by convenient sampling within the period of October 2015 to December 2016. Data were collected through face-to-face interview with Female Sexual Function Index (FSFI) questionnaire. The results showed that, most (95.95%) of the patients were in the reproductive age group. Majority of the patients (32.95%) were in 26-30 years age group and 24.85% were in 18-25 years age group. Majority (77.5%) belonged to home maker occupational class where 12.7% was service-holder. Fifty six percent of the respondents were found to have sexual dysfunctions and 38.15% patients had endocrinological co-morbidities, 37.57% had gynecological co- morbidities and 33.53% had psychiatric co-morbidities. Positive openness in sexual health is required for the betterment of both treatment and diagnosis of sexual disorders. Specialized service center focusing the different groups is needed to deal with sexual health in a developing country like Bangladesh. Bang J Psychiatry December 2016; 30(2): 27-31

Diagnosis and Assessment of Female sexual Dysfunction(s)

2009 ◽  
Vol 24 (S1) ◽  
pp. 1-1
Author(s):  
R. Balon
Keyword(s):  
Sexual Dysfunction ◽  
Sexual Desire ◽  
Sexual Functioning ◽  
Female Sexual Dysfunction ◽  
Clinical Interview ◽  
Sexual Dysfunctions ◽  
Sexual Distress ◽  
Gynecological Examination ◽  
Female Sexual Functioning ◽  
Distress Scale

The first challenge in diagnosing female sexual dysfunction(s) originates in our diagnostic system. The traditional model of classifying sexual dysfunction is anchored in the sexual response cycle: desire - arousal - orgasm - resolution. However, as some experts have pointed out, this classification may be problematic in the area of female sexuality. Both the diagnoses of female hypoactive sexual desire disorder (FHSDD) and female arousal disorder (FSAD) probably need to be redefined and refined. Examples include adding the lack of responsive desire to the FHSDD criteria and creating categories of subjective FSAD and genital FSAD.The second challenge in diagnosis female dysfunction is the lack of solid diagnostic instruments, diagnosis-specific laboratory assays and other specific testing. Specific measures of female sexual functioning, such as Female Sexual Functioning Index, Profile of Female Sexual Functioning, Sexual Function Questionnaire, Sexual Desire and Interest Inventory, and Female Sexual Distress Scale were mostly developed as outcome measures. No solid diagnostic instrument for sexual dysfunction exists, not even a version of the Structured Clinical Interview for DSM sexual dysfunctions. The contribution of imaging techniques, such as ultrasonography, magnetic resonance imaging or thermography, to the diagnosis is unclear, and these techniques are far (if ever) from clinical use.Thus, a detailed comprehensive clinical interview combined with physical examination, possibly a gynecological examination, and in some cases laboratory hormonal testing remains the cornerstone of diagnosing and assessing female sexual dysfunctions.

Sign in / Sign up

Export Citation Format

Share Document